Delivery Order SPE2DB22D3004-SPE2DB24FPE91
Award Date 2/2/24
Potential Completion Date 2/5/24
Potential Value $3.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,989.24 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide MENVEO A-C-Y-W KIT (2 VIALS)S. The contract has a completion date of March 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and has no major subcontractors listed. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that DLA...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $3,216.90. It was issued by the Defense Logistics Agency (DLA) for the procurement of 4,565,064,936 units of the MENVEO A-C-Y-W KIT (2 VIALS). This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award is a delivery order for the MENVEO A-C-Y-W KIT (2 VIALS)S, awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,895.65 firm fixed-price contract has a completion date of June 10, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MENVEO A-C-Y-W KIT (2 VIALS). The $7,028.88 firm fixed-price contract has a completion date of February 2, 2023 and does not utilize any set-aside designations. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of MENVEO A-C-Y-W KIT (2 VIALS)S, a pharmaceutical product, under a firm fixed price delivery order. The contract has a ceiling value of $3,860.28 and a period of performance through March 13, 2024....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $3,079.34 firm fixed price delivery order is for the supply of MENVEO 1 VIAL-A-C-Y-W-135-DIP 0.5ML, a pharmaceutical product. This award does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award, valued at $16,537.97, is for the delivery of 4566111012 - MENVEO A-C-Y-W KIT (2 VIALS)S. This is a firm fixed price delivery order contract with an ultimate completion date of October 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at $6,433.80 by the Defense Logistics Agency (DLA). The award is for the provision of MENVEO A-C-Y-W KIT (2 VIALS), a pharmaceutical product, to support military treatment programs and facilities. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,652.00 Firm Fixed Price Delivery Order is for the procurement of MENVEO A-C-Y-W KIT (2 VIALS), a vaccine product. The contract has an ultimate completion date of December 3, 2024 and was awarded on December 2, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,652.00 firm fixed-price delivery order is for the procurement of MENVEO A-C-Y-W KIT (2 VIALS) medical supplies. The contract has an ultimate completion date of December 10, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FPE91Delivery Order
This federal contract award is a $3,860.28 firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation. The order is for the supply of the MENVEO A-C-Y-W KIT (2 VIALS)S pharmaceutical product, with a completion date of February 5, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this order, which is not associated with any set-aside designation. The company also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide.
Generated 5/3/24, 9:41 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 2/2/24 |